We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
iShares Russell 3000 ETF
IWV
$19.7B
| $15.8M | 0.05% |
109,450
-1,287
| -1% | -$183K |
|
252
Bristol-Myers Squibb
BMY
$124B
| $15.6M | 0.05% |
280,513
-10,655
| -4% | -$580K |
|
253
Nike
NKE
$62.6B
| $15.6M | 0.05% |
263,994
-234,273
| -47% | -$12.6M |
|
254
Monolithic Power Systems
MPWR
$68.7B
| $15.6M | 0.05% |
+161,472
| New | +$15.4M |
|
255
VF Corp
VFC
$6.74B
| $15.2M | 0.05% |
280,636
-2,394
| -0.8% | -$124K |
|
256
Labcorp
LH
$23.1B
| $14.9M | 0.05% |
112,158
+76,080
| +211% | +$9.32M |
|
257
Canadian Pacific Kansas City
CP
$81.1B
| $14.7M | 0.05% |
457,570
+438,295
| +2,274% | +$13.6M |
|
|
ABB
258
DELISTED
ABB Ltd
ABB
| $14.7M | 0.04% |
590,098
+577,351
| +4,529% | +$14.2M |
|
|
PFPT
259
DELISTED
Proofpoint, Inc.
PFPT
| $14.6M | 0.04% |
168,595
+3,108
| +2% | +$256K |
|
|
MRSH
260
Marsh
MRSH
$84B
| $14.5M | 0.04% |
185,833
+1,906
| +1% | +$144K |
|
261
Lindblad Expeditions
LIND
$1.82B
| $14.3M | 0.04% |
1,365,396
-17,800
| -1% | -$168K |
|
|
SRCL
262
DELISTED
Stericycle Inc
SRCL
| $14.3M | 0.04% |
187,430
+136,069
| +265% | +$11.2M |
|
|
NVDQ
263
DELISTED
Novadaq Technologies Inc.
NVDQ
| $14.3M | 0.04% |
1,216,804
+15,917
| +1% | +$126K |
|
|
EFII
264
DELISTED
Electronics for Imaging
EFII
| $14.2M | 0.04% |
299,285
-78,366
| -21% | -$3.74M |
|
265
W.W. Grainger
GWW
$63.9B
| $14.2M | 0.04% |
78,464
-1,614
| -2% | -$305K |
|
266
United Bankshares
UBSI
$6.46B
| $14.1M | 0.04% |
360,284
+28,395
| +9% | +$1.13M |
|
|
ENT
267
DELISTED
Global Eagle Entertainment Inc.
ENT
| $13.9M | 0.04% |
155,932
+2,690
| +2% | +$207K |
|
268
Agios Pharmaceuticals
AGIO
$2.14B
| $13.8M | 0.04% |
268,403
+4,861
| +2% | +$249K |
|
269
Vanguard Mid-Cap ETF
VO
$106B
| $13.7M | 0.04% |
383,628
-26,072
| -6% | -$921K |
|
270
Marriott International
MAR
$97.5B
| $13.6M | 0.04% |
136,053
-7,362
| -5% | -$737K |
|
271
EOG Resources
EOG
$76.7B
| $13.6M | 0.04% |
150,270
+2,808
| +2% | +$259K |
|
|
SNI
272
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $13.6M | 0.04% |
199,126
+193,337
| +3,340% | +$13.6M |
|
|
WAGE
273
DELISTED
WageWorks, Inc.
WAGE
| $13.3M | 0.04% |
197,414
-87,187
| -31% | -$6.2M |
|
|
CTXS
274
DELISTED
Citrix Systems Inc
CTXS
| $13.2M | 0.04% |
166,428
+143,607
| +629% | +$11.9M |
|
|
XLRN
275
DELISTED
Acceleron Pharma
XLRN
| $13.2M | 0.04% |
434,924
+6,000
| +1% | +$174K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.